LRRK2 and Parkinson disease: RIT2 has been shown to activate LRRK2 (Obergasteiger et al., 2023), and vulnerability of RIT2-underexpressing dopaminergic neurons has been reported from analysis of postmortem brains of PD patients (Wang et al., 2024).